Lotus Pharmaceutical (Taiwan) Today
| 1795 Stock | TWD 285.50 4.00 1.42% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Lotus Pharmaceutical is selling for under 285.50 as of the 26th of November 2024; that is 1.42 percent increase since the beginning of the trading day. The stock's lowest day price was 281.5. Lotus Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Lotus Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited. LOTUS PHARMACEUTICAL operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.. The company has 262.04 M outstanding shares. More on Lotus Pharmaceutical Co
Moving against Lotus Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lotus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lotus Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lotus Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Lotus Pharmaceutical Co (1795) is traded on Taiwan Stock Exchange in Taiwan and employs 10 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 70.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Pharmaceutical's market, we take the total number of its shares issued and multiply it by Lotus Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lotus Pharmaceutical operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 262.04 M outstanding shares.
Lotus Pharmaceutical Co has accumulated about 1.97 B in cash with 119.66 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.02.
Check Lotus Pharmaceutical Probability Of Bankruptcy
Ownership AllocationLotus Pharmaceutical maintains a total of 262.04 Million outstanding shares. Lotus Pharmaceutical Co secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.63 % of Lotus Pharmaceutical Co outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lotus Ownership Details
Lotus Pharmaceutical Risk Profiles
Although Lotus Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Lotus Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.39 | |||
| Semi Deviation | 1.5 | |||
| Standard Deviation | 1.99 | |||
| Variance | 3.97 |
Lotus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lotus Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Lotus Pharmaceutical Corporate Management
Elected by the shareholders, the Lotus Pharmaceutical's board of directors comprises two types of representatives: Lotus Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lotus. The board's role is to monitor Lotus Pharmaceutical's management team and ensure that shareholders' interests are well served. Lotus Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lotus Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Petar Vazharov | GM Director | Profile | |
| Bjartur Shen | VP Fin | Profile | |
| Charles Lin | Strategic Consultant | Profile | |
| Eeling Chan | Chief Officer | Profile | |
| Zenon Zdunek | VP Operations | Profile | |
| Saral Thangam | Chief Services | Profile | |
| Angela Luan | Corp Director | Profile |
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.